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Vinyl chloride (VCM) is not carcinogenic by itself. it is bioactivated to the highly
reactive alkylating oxirane chloroethylene oxide. Further metabolism, apparently, leads
via an interaction of the primary alkylating metabolites with glutathion to S-(2-carboxy-
methyl)-cysteine and thiodiacetic acid which are eliminated with the urine. Up to now,
it has not been ascertained whether the oxirane alone is the essential carcinogenic factor
or whether other metabolites are also involved in carcinogenicity. Likewise, it is still
unknown whether the metabolites excreted in the urine might be used as biological
criteria for exposure to VCM, because these metabolites probably can originate from a
series of substances other than VCM. This problem could stimulate investigations on the
possible carcinogenic activity of these substances.
Studies on the pathway of the carcinogenic
and mutagenic activity of vinyl chloride (VC)
are not only of interest in relation to this spe-
cial substance. Such studies also allow further
insight into the possibly carcinogenic and muta-
genic mechanism of chemically related sub-
stances which are suspected to be dangerous
in occupational exposure. Furthermore, the
knowledge of carcinogenic metabolites may
furnish us with biochemical criteria to judge
the dimension of risk in exposure to potentially
carcinogenic and mutagenic substances.
Moreover, research into the carcinogenic ac-
tivity of VC becomes more and more interesting
when we just learn that also tobacco smoke
contains about 30 ppb of VC, a concentration
which may not be important per se, but which
could assume increased importance in connec-
tion with the other carcinogenic substances
contained in the smoke (1).
I want to report briefly some investigations
which were performed in our country quite
recently by Norpoth and co-workers in a work-
ing group in Munster in the Department of
Occupational Medicine and the hypothesis de-
rived from the results of these experiments.
In 1966 Grigorescu and Toba (2) had found
chloroacetic acid as a metabolite of VC. This
was confirmed in 1974 by Hefner and co-work-
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ers (3) and in 1975 by Radwan and Henschler
(4).
Bartsch and colleagues (5) then supposed
that the presumed intermediary metabolite,
chloroethylene oxide, would be really the active
alkylating substance because this substance
proved to be a strong mutagen as well as VC
in the presence of an oxygenating system. Its
mutagenic activity in certain sensitive bacteria
was superior to the activity of chloroacetalde-
hyde and chloroacetic acid.
About the same time Green and Hathway
(6) as well as Norpoth and co-workers (7)
identified thiodiacetic acid as a conjugated
metabolite in the urine of rats which inhaled
VC. This finding was in good agreement with
the statement of Hefner and colleagues that
free SH-groups in the liver, not bound to pro-
teins, are strongly used by VC and its meta-
bolites respectively. Reynolds et al. (8), how-
ever, were not able to confirm a loss of SH
groups. On the contrary, they reported an in-
crease of SH groups. It is not yet clear if this
can be explained as a rebound effect.
Hefner et al. supposed S-(2-carboxymethyl)
cystein to be a further metabolite. This com-
pound has since been confirmed a metabolite
of VC by Norpoth and co-workers. Since Yllner
(9, 10) also found this substance and addi-
tionally also thiodiacetic acid to be the main
metabolite of chloroacetic acid in experiments
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ested in the problem of coincidence of metabo-
lism in mice and men. They analyzed urine
samples of patients- who were given Ifosfamid,
an analog of cyclophosphamide, and stated that
a chloroethyl group is cleaved by side-chain
oxidation so that choloroacetaldehyde can be
produced Indeed, its metabolites could be iden-
tified as thiodiacetic acid and S-carboxymethyl
cysteine. Estimation of the dechloroethylated
products shows about 80%7c of the value related
to these products to analyze as thiodiacetic acid
and S-(2-carboxymethyl) cystein. Thus, the
results in mice and men seem to be in agree-
ment (11).
Norpoth and colleagues have found thiodi-
acetic acid also to be a metabolite of dichlorodi-
ethyl ether. Thus, conversion to chloroacetalde-
hyde is very probable. Chloroacetaldehyde itself
may be a carcinogenic substance. With VC cer-
tainly the additional formation of chloroethyl-
ene oxide is an important factor.
When we try to get a synopsis of the results
in metabolic research of VC as presented in the
reaction scheme (1), the first oxidation step is
followed by a chain of detoxicating reactions,
some of which occur spontaneously and some
of which are enzyme-catalized. The first three
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alkylating substances are of decreasing toxicity.
They can have biologically alkylating activity,
or they may be detoxicated stepwise. Chloro-
acetaldehyde and chloroacetic acid are known
to be toxic substances. New animal experiments
by van Duuren (12), however, did not prove
chloroacetic acid to be a carcinogen.
The results of investigations of Henschler
and co-workers (13) could be interpreted to
indicate that all precursors of oxiranes which
are not symmetrically halogen substituted, such
as trichloroethylene, and also vinylidene chlo-
ride, vinyl bromide, vinylidene bromide, per-
haps also vinyl iodide, may be carcinogenic.
Regarding the development of biological cri-
teria for dangerous, carcinogenic, and muta-
genic exposure, we have still the problem of
the specificity of the criterion.
Thiodiacetic acid can probably originate
from: 2-chloroethanol, 2-bromacetic acid, chlo-
roacetic acid, chloroacetaldehyde, bromacetalde-
hyde, 1,2-dichloroethane, 1,2-dibromoethane,
and 1,1,2-trichloroethane.
All drugs containing oxidatively cleavable
chloroethyl side chains, such as cyclophospha-
mide, for instance, are supposed to cause devel-
opment of thiodiacetic acid.
These hypotheses likewise might be discussed
for S-(2-carboxymethyl)cysteine which has also
been shown to be a naturally occurring sub-
stance in the intermediary metabolism.
Most of these investigations have been in-
cluded in vitro tests in mutagenicity. As there
exists a close correlation between carcinogenic
and mutagenic effects of chemical substances
I feel that at present there exists no better pos-
sibility to learn about the metabolic activation
of carcinogenic substances in a reasonably
short time. It should be considered also that
there are some difficulties in the interpretation
of such experiments, as, for example, in the
case of English research workers who just
recently were not able to find a mutagenic effect
in mice with the dominant lethal test when
they exposed the animals to concentrations up
to 30,000 ppm of VC.
REFERENCES
1. Hoffmann, D., et al. Chromatographic determina-
tion of vinyl chloride in tobacco smoke. Anal.
Chem. 48: 47 (1976).
2. Grigorescu, I., and Toba, G. H. Clorura di vinyl.
Aspecte de toxicologie industriala. Rev. Chim. Rom.
17: 499 (1966).
218 Environmental Health Perspectives3. Hefner, R. E., Jr., Watanabe, P. G., and Gehring,
P. J. Preliminary studies of the fate of inhaled
vinyl chloride monomer in rats. Ann. N.Y. Acad.
Sci. 246: 143 (1975).
4. Radwan, Z., and Henschler, D. Uptake and metab-
olism of vinyl chloride in the isolated perfused rat
liver preparation. Naunyn Schmiedebergs Arch.
Exp. Path. Pharmak. Suppl. 287: 100 (1975).
5. Malaveille, C., et al. Mutagenicity of vinyl chloride,
chloroethylenoxide, chloroacetaldehyde and chloro-
ethanol. Biochem. Biophys. Res. Comm. 63; 363
(1975).
6. Green, T., and Hathway, D. E. The biological fate in
rats of vinyl chloride in relation to its oncogenicity.
Chem. Biol. Interactions 11: .545 (1975).
7. Muller, G., and Norpoth, K. Bestimmung zweier
Urinmetabolite des Vinylchlorids. Naturwiss. 62:
541 (1975).
8. Reynolds, E. S., et al. Hepatotoxicity of vinyl
chloride and 1,1-dichloroethylene. Am. J. Pathol.
81: 219 (1975).
9. Yllner, S. Metabolism of 1,2-dichloroethane-14C in
the mouse. Acta Pharmacol. Toxicol. 30: 257 (1971).
10. Yllner, S. Metabolism of chloroacetate-1-"C in the
mouse. Acta Pharmacol. Toxicol. 30: 69 (1971).
11. Norpoth, K.: Studies on the metabolism of Ifos-
famide in man. Cancer Treatment Reports, 60: 437
(1976).
12. Van Duuren, B. L., Carcinogenic activity of alky-
lating agents. J. Nat. Cancer Inst. 53: 695 (1974).
13. Greim, H., et al. Mutagenicity in vitro and potential
carcinogenicity of chlorinated ethylenes as a func-
tion of metabolic oxirane formation. Biochem. Phar-
macol. 24: 2013 (1975).
October 1976 219